Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Food Effect of DSM265 Granules in Healthy Adults
NCT02750384Phase 1Terminated
- Sponsor
- Medicines for Malaria Venture
- Start
- May 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of DSM265 in malaria (3 arms), sponsored by Medicines for Malaria Venture. Primary endpoints: Maximum Observed Plasma Concentration at 480 hours, Time to Maximum Concentration at 480 hours and 5 more. Started May 2016; status: terminated.
02
Drugs
DSM265
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02750384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02750384.